Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1452)
- Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis. (2022/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary sclerosing cholangitis-A long night's journey into day. (2022/12/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. (2022/12/08) ♡
- Factors associated with severity and persistence of fatigue in patients with primary biliary cholangitis: study protocol of a prospective cohort study with a mixed-methods approach (SOMA.LIV). (2022/12/07) ♡
- Antibiotic prophylaxis and its effect on postprocedural adverse events in endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis. (2022/12/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Covid-19-associated secondary sclerosing cholangitis - A case series of 4 patients. (2022/12/01) ♡
- PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Practical Guide for Radiological Diagnosis of Primary and Secondary Sclerosing Cholangitis. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Successful Management of Adult-Onset Linear IgA Bullous Disease With Sulfasalazine During the COVID-19 Pandemic. (2022/12/01) ♡
- Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer. (2022/12/01) ♡
- Pediatric liver transplantation for autoimmune liver disease: Ten-year experience from a liver transplant center in India. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. (2022/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autoimmune hepatitis after COVID-19 vaccination. (2022/11/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Relapsing Polychondritis in a Patient With Auricular Chondritis and Inflammatory Bowel Disease: A Case Report With Literature Review. (2022/11/21) ♡
- Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysis. (2022/11/19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis. (2022/11/18) ♡
- A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients. (2022/11/17) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease. (2022/11/15) ♡
- The clinical significance of biliary findings in magnetic resonance enterography of patients with inflammatory bowel disease (2022/11/12) ♡
- Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease. (2022/11/04) ♡
- ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities. (2022/11/04) ♡
- PR3-Ancas Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis. (2022/11/03) ♡
- Symptom Classes in Decompensated Liver Disease. (2022/11/01) ♡
- Waitlist mortality in patients with autoimmune liver diseases. (2022/11/01) ♡
- Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut-liver axis: Pathophysiological concepts and clinical implications. (2022/11/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Berberine Ursodeoxycholate for the Treatment of Primary Sclerosing Cholangitis: The Search for the Elusive Pharmacologic Holy Grail Will Need to Continue. (2022/11/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Long-term Care of the Adult Liver Transplant Recipient. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in surveillance colonoscopy for dysplasia in inflammatory bowel disease. (2022/11/01) ♡
- Highly Increased Levels of Inter-α-Inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases (2022/10/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Surveillance imaging in primary sclerosing cholangitis (PSC): evidence, patient preference, and physician autonomy. (2022/10/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid. (2022/10/23) ♡
- A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19. (2022/10/21) ♡
- Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells via VEGFR-3 regulation of VE-Cadherin. (2022/10/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. (2022/10/17) ♡
- Trends in liver transplantation for autoimmune liver diseases: a Canadian study. (2022/10/12) ♡
- Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia. (2022/10/11) ♡
- Sclerosing Cholangitis Owing to Langerhans Cell Histiocytosis. (2022/10/07) ♡
- Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001). (2022/10/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? (2022/10/04) ♡
- Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients. (2022/10/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. (2022/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. How frequently are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin? (2022/10/01) ♡
- Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study. (2022/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HLA Associations in pediatric autoimmune liver diseases: Current state and future research initiatives. (2022/09/29) ♡
- Development of a prognostic MRCP (DiReCiCT) score for individuals with large-duct primary sclerosing cholangitis. (2022/09/22) ♡
- Benefit of endoscopic stenting for dominant strictures in patients with primary sclerosing cholangitis. (2022/09/14) ♡
- Feasibility of a new electronic patient-reported outcome (ePro) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (ProMICS): protocol for a qualitative feasibility study. (2022/09/06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.